Skip to main navigation Skip to search Skip to main content

Severe adverse cutaneous reactions to drugs

  • Francisco J. Fernández-Fernández
  • , J. A. Garrido
  • , Manfred Hauben
  • , Joost P. h. Drenth
  • , Jan Jacques Michiels
  • , Luke Hughes-Davies
  • , Robert S. Stern
  • , Jean Claude Roujeau
  • Complexo Hospitalario Universitario de Ferrol
  • Pfizer
  • Radboud University Medical Center
  • Erasmus MC
  • Brigham and Women’s Hospital
  • Beth Israel Deaconess Medical Center
  • Hôpital Henri Mondor

Research output: Contribution to journalComment/Letter to the editorAcademic

Abstract

To the Editor: In their excellent review of cutaneous reactions to drugs (Nov. 10 issue), Roujeau and Stern1 include vasculitis associated with lymphomas in the differential diagnosis of drug-induced vasculitis. Cutaneous vasculitis has also been associated, although infrequently, with solid tumors.2,3 Among hematologic cancers, leukemias have been associated with cutaneous vasculitis more often than lymphomas have.2 The dermatologic manifestations may antedate the discovery of the neoplasia, and pathologically, the most common manifestation is a leukocytoclastic vasculitis. To the Editor: A mechanism by which warfarin and related compounds may cause skin and digital necrosis, which Roujeau and Stern do not. © 1995, Massachusetts Medical Society. All rights reserved.
Original languageEnglish
Pages (from-to)959-960
JournalNew England journal of medicine
Volume332
Issue number14
DOIs
Publication statusPublished - 6 Apr 1995
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Severe adverse cutaneous reactions to drugs'. Together they form a unique fingerprint.

Cite this